JPRN-UMIN000014291已完成2 期
Phase II study of combination chemotherapy with cisplatin / pemetrexed / bevacizumab in patients with relapsed nonsquamous non-small cell lung cancer - SMU Th-R1
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •nervous system metastasis haemoptysis
研究者
相似试验
尚未招募
1 期
Phase 1/2 study of combination chemotherapy with Carboplatin, nab-Paclitaxel, and Bevacizumab for advanced non-squamous non-small cell lung canceron-squamous Non-small-cell Lung CancerJPRN-UMIN000016735Hiroshima Asa City Hospital35
已完成
2 期
Phase II study of combination chemotherapy with mitomycin and methotrexate for triple negative breast cancerBreast CancerJPRN-UMIN000003512Cancer Institute Hospital, Japanese Foundation for Cancer Research70
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30
已完成
2 期
Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumorsmedulloblastoma or supratentorial primitive neuroectodermal tumorsJPRN-UMIN000000546Japanese Pediatric Brain Tumor Consortium40
已完成
不适用
Phase II study of second-line chemotherapy using CPT-11 plus CDDP in patients with advanced/recurrent gastric cancer (OGSG 0504)Advanced/Recurrent gastric cancer which has no response to S-1JPRN-UMIN000000693Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)35